The role of cytokines of the innate and adaptive immune system in the regulation of insulin resistance Dear Sir, Pickup and Crook [1] suggested the role of a hypersensitive acute-phase response in the developement of Type II (non-insulin-dependent) diabetes mellitus and metabolic X-syndrome due to the maladaptation of the innate immune system. Although we do not deny that the genetically determined components of the immune system have a basic role in the monitorization and control of the metabolic processes of the body, we would like to emphasize that the participation of the adaptive immune system in the metabolic regulation might also be of importance. Namely, the source of a higher cytokine concentration or an altered composition of the cytokine profile evoked during the course of the immune response could be not only the innate but also the adaptive immune system. Moreover, cytokines, their membrane-bound forms and soluble receptors have a double role in the regulation of insulin sensitivity or resistance or both: of these more than one can cause an increase in insulin sensitivity, e. g. injecting fa/fa rats with interleukin (IL)-1 decreased insulin resistance [2] , tumour necrosis factor (TNF) receptor-IgG fusion protein decreased insulin resistance in obese animals [3] , whereas others such as TNF-a increase insulin resistance [4] . Several data also support the contribution of cellular components in this regulation.
In the KK-Ay animal model of Type II diabetes allogenic bone marrow transplantation prevented Type II diabetes, also immunization with streptococcal preparations improved glucose tolerance [5] . Oral treatment with Lactobacillus casei proved to be antidiabetogenic in this mouse model by decreasing the CD4 + T-cell function especially by decreasing interferon-gamma and IL-2 cytokine production [6].
We have observed that Th-1 type cytokine IL-12 plasma concentration is higher in Type II diabetic patients, not only in those with retinopathy but also in those not having microvascular complications [7] . We calculated positive linear correlations between TNF-a and IL-12 (r s = 0.60, p < 0.01) as well as between IL-12 and C-peptide (r s = 0.58, p < 0.02) (unpublished data). Accordingly we suggest that IL-12, the cytokine connecting innate and adaptive immunity also has a role in Type II diabetes.
We have also studied serum TNF-a immunoreactive concentrations in patients with gestational diabetes and healthy pregnant women matched with them. The serum TNF-a proved to be two times higher in diabetic patients, increasing with gestational age, than in non-diabetic pregnant women in the same gestational period (unpublished data). These data also support a role for alteration of the immune system in insulin-resistant syndromes.
One unpublished observation of ours is that an elderly patient with Type II diabetes and clear cell renal cancer who had reached a euglycaemic state with diet only subsequently developed pronounced insulin resistance, requiring as much as 60 units of insulin daily, during 3 months when she was treated with a high dose of IL-2 (three times 18 Million Units per day). After stopping this treatment the insulin resistance disappeared and the patient became euglycaemic again with diet only. We assume there was either a reversible suppression of insulin production of the beta-cells or a further deterioration of insulin sensitivity.
In conclusion, we suggest both innate and adaptive immunity have a role in metabolic regulation, producing the same cytokines with their soluble receptors either increasing or decreasing insulin resistance. At present, it is hard to distinguish whether the cytokine profile contributing to insulin resistance originates exclusively from the maladaptation of the innate immunological response, or if it is a disregulation of both the innate and adaptive immune system. Yours sincerely, K. Cseh, É. Baranyi, G. Winkler
